Hepatitis B co-infection in HIV-infected patients receiving antiretroviral therapy at the TC Newman Anti Retroviral Treatment Clinic in Paarl, Western Cape
Southern African Journal of HIV Medicine
Field | Value | |
Title | Hepatitis B co-infection in HIV-infected patients receiving antiretroviral therapy at the TC Newman Anti Retroviral Treatment Clinic in Paarl, Western Cape | |
Creator | King, Jeanmari Hagemeister, Dirk T. | |
Description | Background: Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) co-infection in South Africa is estimated to be between 5% and 23%; however, only limited evidence is available. Co-infection increases the risk of chronification of HBV, liver cirrhosis and death.Objective: To assess the HBV and/or HIV co-infection rate amongst the adult antiretroviral treatment cohort at the TC Newman ART Clinic in Paarl, Western Cape.Methods: In a retrospective, cross-sectional study, the routine hepatitis B surface antigen screening results for all adult HIV patients who were started on antiretroviral treatment over a period of 19 months were collected and analysed for gender, CD4 count and age.Results: Amongst the 498 participants (60% female participants), the Hepatitis B surface Antigen positivity rate was 7.6%. Male gender, age between 50 and 59 years and a low CD4 count were correlated with higher rates.Conclusion: Useful insight could be obtained by analysing routine data. The prevalence of almost 8% confirms the need for testing of HIV-positive patients for hepatitis B.Keywords: hepatitis B; prevalence; HIV-infected; adults; co-infection | |
Publisher | AOSIS | |
Date | 2016-05-20 | |
Identifier | 10.4102/sajhivmed.v17i1.336 | |
Source | Southern African Journal of HIV Medicine; Vol 17, No 1 (2016); 3 pages 2078-6751 1608-9693 | |
Language | eng | |
Relation |
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:
https://sajhivmed.org.za/index.php/hivmed/article/view/336/810
https://sajhivmed.org.za/index.php/hivmed/article/view/336/811
https://sajhivmed.org.za/index.php/hivmed/article/view/336/812
https://sajhivmed.org.za/index.php/hivmed/article/view/336/800
|
|
ADVERTISEMENT